SBD

Science PT ↓ 500 episodes

Acompanhe as últimas novidades sobre o diabetes, tratamentos e muito mais, com os Podcasts da Sociedade Brasileira de Diabetes, exclusivos para profissionais da saúde. Os programas contarão com a participação de grandes diabetologistas brasileiros, comentando artigos nacionais e internacionais, para que você esteja sempre bem informado sobre as últimas tendências.

Author

SBD

Episodes

P130 - Complicações microvasculares - Luís Canani 17.10.2019 9:37

P130 - Complicações microvasculares - Luís Canani by SBD

P129 - Dos guidelines à prática clínica - Maria Helane Gurgel Castelo 10.10.2019 10:52

P129 - Dos guidelines à prática clínica - Maria Helane Gurgel Castelo by SBD

Podcast 128 - Complicações macrovasculares - Cynthia Valerio 04.10.2019 8:39

Podcast 128 - Complicações macrovasculares - Cynthia Valerio by SBD

P127 - Hipoglicemia e desfechos CV - João Roberto de Sá 27.09.2019 9:52

P127 - Hipoglicemia e desfechos CV - João Roberto de Sá by SBD

P126 - Diagnóstico e manejo do DM2 - Rosângela Réa 18.09.2019 10:02

P126 - Diagnóstico e manejo do DM2 - Rosângela Réa by SBD

P125 - Relação dose de insulina basal e controle glicêmico em DM2 - Fernando Valente 26.08.2019 5:45

Ref: When basal insulin is not enough: A dose-response relationship between insulin glargine 100 units/mL and glycaemic control. Diabetes Obes Metab. 2019 Jun;21(6):1305-1310.

P124 - Semaglutida em DM2 com insulina - estudo SUSTAIN 5 - Luciano Giacaglia 19.08.2019 9:38

Ref: Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial. J Clin Endocrinol Metab. 2018 Jun 1;103(6):2291-2301.

P123 - Segurança CV da Dulaglutida - estudo REWIND - Roberto Betti 08.08.2019 3:33

Ref: Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019 Jul 13;394(10193):121-130.

P122 - Consumo de bebidas açucaradas e mortalidade - Bianca de Almeida Pitito 01.07.2019 7:23

Ref: Association of Sugary Beverage Consumption With Mortality Risk in US Adults: A Secondary Analysis of Data From the REGARDS Study. JAMA Netw Open. 2019 May 3;2(5):e193121.

P121 - Incidência e prevalência de DM nos EUA - Bianca de Almeida Pitito 19.06.2019 5:10

New directions in incidence and prevalence of diagnosed diabetes in the USA. BMJ Open Diab Res Care 2019;7:e000657.

P120 - Metformina na prevenção de DM2 - seguimento DPP - Fernando Valente 10.06.2019 7:23

Ref: Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care. 2019 Apr;42(4):601-608.

P119 - Hipolipemiante reduz risco de retinopatia em DM2 - Solange Travassos 21.05.2019 5:01

Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real-world observational analysis of a health claims database. Diabetes Obes Metab. 2018 Oct;20(10):2351-2360.

P118 - Canagliflozina em DM2 e DRC - estudo CREDENCE - Mateus Dornelles Severo 13.05.2019 11:23

Ref: Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019 Apr 14.

P117 - Relação A1c e tempo no alvo - Mônica Gabbay 30.04.2019 6:08

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes. Diabetes Technol Ther. 2019 Feb;21(2):81-85.

P116 - Associação hipoglicemia bioquímica e hipoglicemia grave - Mônica Gabbay 15.04.2019 7:17

The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data Set. Diabetes Technol Ther. 2019 Jan;21(1):1-5.

P115 - Comparação de desfechos CV e renais aGLP1 e iSGLT2 - Euler Manenti 08.03.2019 9:33

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Co-Transporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials. Circulation. 2019 Feb 21.

P114 - Irisina ligada ao exercício melhora memória de modelos de Alzheimer - João E. Nunes Salles 14.02.2019 4:40

Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models. Nat Med. 2019 Jan;25(1):165-175.

P113 - Glucagon na prevenção da hipoglicemia induzida pelo exercício em DM1 - Roberto Zagury 23.01.2019 18:56

Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes. Diabetes Care. 2018 Sep;41(9):1909-1916.

P112 - Revisão Sistemática E Metanálise Dos Desfechos CV E Renais Dos ISGLT2 - Euler Manenti 20.12.2018 8:44

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2018 Nov 9.

P111 - Segurança CV da Dapagliflozina - estudo DECLARE - Carlos Eduardo Barra Couri 13.12.2018 13:32

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2018 Nov 10.

P110 - Hiperandrogenismo e secreção de insulina - Cristiano Barcelos 04.12.2018 10:22

Increased androgen levels in rats impair glucose-stimulated insulin secretion through disruption of pancreatic beta cell mitochondrial function. J Steroid Biochem Mol Biol. 2015 Nov;154:254-66.

P109 - Metformina em DM1 - metanálise - Mônica Gabbay 23.11.2018 6:17

Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials. Diabetes Metab Res Rev. 2018 May;34(4):e2983.

P108 - Consenso internacional de monitorização contínua da glicose - André Vianna 06.11.2018 9:30

International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017 Dec;40(12):1631-1640.

Terapia anti-plaquetária - I Diretriz conjunta de DM e prevenção de DCV SBC, SBEM e SBD - Cynthia V. 26.10.2018 3:46

Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM). Diabetol Metab Syndr. 2017 Jul 14;9:53

Tratamento da HAS - I Diretriz conjunta de DM e prevenção de DCV SBC, SBEM e SBD - Cynthia Valerio 17.10.2018 5:40